Dulaglutide has higher adherence and persistence than liraglutide and exenatide QW: 1-year follow-up from US real-world data

被引:0
|
作者
Lando, L. Fernandez [1 ]
Mody, R. [1 ]
Huang, Q. [2 ]
Yu, M. [3 ]
Zhao, R. [2 ]
Patel, H. [1 ]
Grabner, M. [2 ]
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] HealthCore Inc, Wilmington, DE USA
[3] Eli Lilly & Co, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
760
引用
收藏
页码:S372 / S372
页数:1
相关论文
共 50 条
  • [11] Depressed Mood in First Episode Schizophrenia: Findings From a 1-Year Follow-Up in an Italian Real-World Care Setting
    Pelizza, Lorenzo
    Leuci, Emanuela
    Quattrone, Emanuela
    Paulillo, Giuseppina
    Azzali, Silvia
    Pupo, Simona
    Pellegrini, Pietro
    PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES, 2023, 86 (02): : 164 - 166
  • [12] Real-World 1-Year HbA1c and Weight Outcomes in Patients Treated with Exenatide Once Weekly or Liraglutide Once Daily
    Mcadam-Marx, Carrie
    Nguyen, Hiep
    Schauerhamer, Marisa
    Ye, Xiang-Yang
    Singhal, Mukul
    Cobden, David
    DIABETES, 2015, 64 : A296 - A296
  • [13] Real-world effectiveness and safety of perampanel for children and adolescents with epilepsy: A meta-analysis with at least 1-year follow-up
    Weng, Yijun
    Ma, Bihong
    Lin, Xi
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2024, 122 : 96 - 104
  • [14] Incremental progress but still far from good enough: real-world LDL-cholesterol insights from the SANTORINI 1-year follow-up study
    Dalakoti, Mayank
    Angoulvant, Denis
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (15) : 1804 - 1805
  • [15] Real world experience with lacosamide monotherapy- a single center 1-year follow-up study
    Maloney, Eimer
    McGinty, Ronan N.
    Costello, Daniel J.
    EPILEPSY RESEARCH, 2018, 142 : 16 - 19
  • [16] INFLIXIMAB, ADALIMUMAB AND ETANERCEPT, A FIVE-YEAR FOLLOW-UP FROM A REAL-WORLD COHORT
    Valencia, Omaira
    Santos, Pedro
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S59 - S59
  • [17] Pronova sirolimus-eluting stents in a real-world setting: A single-center 1-year follow-up study.
    Puri, A.
    Singhal, A.
    Mukerjee, S.
    Dwivedi, S. K.
    Narain, V. S.
    Saran, R. X.
    Puri, V. K.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08): : 58F - 58F
  • [18] Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey
    Pisters, Ron
    Nieuwlaat, Robby
    Prins, Martin H.
    Le Heuzey, Jean-Yves
    Maggioni, Aldo P.
    Camm, A. John
    Crijns, Harry J. G. M.
    EUROPACE, 2012, 14 (05): : 666 - 674
  • [19] Real-world data of ocrelizumab effects on disability progression; A 2-year follow-up study
    Baba, C.
    Kaya, E.
    Ozcelik, S.
    Ozdogar, A. T.
    Sagici, O.
    Dastan, S.
    Ozakbas, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 860 - 860
  • [20] 'Simplicity' radiofrequency neurotomy of sacroiliac joint: a real life 1-year follow-up UK data
    Reddy, Vinay S. Anjana
    Sharma, Chhaya
    Chang, Kuang-Yi
    Mehta, Vivek
    BRITISH JOURNAL OF PAIN, 2016, 10 (02) : 90 - 99